In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
New measures to limit the unavailability of medicines – Impact on professional stakeholders

New measures to limit the unavailability of medicines – Impact on professional stakeholders

by In2Pharma | Jun 7, 2019 | News

Belgium On 18 May 2019, a new law amending the law of 25 March 1964 on medicines entered into force. This amendment should reduce one of the causes of the temporary unavailability of certain medicines for Belgian patients. It intends to do so by preventing that...

Recent Posts

  • Update Notification Form “Meldpunt”
  • Planned legislative updates NL
  • Update RD 06.09.2017 pregabalin/gabapentin
  • Update New Inspection Platform GDP – FAMHP
  • Luxembourg tightens rules on nicotine pouches and novel nicotine products from 2026  

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België